Official UK procurement notice
DTaP/IPV 2024 · UK public procurement notice
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought4 lots · detail below
Published requirement descriptionContracts for the supply of combined diphtheria, tetanus and pertussis vaccines, with and without additional poliomyelitis antigen content
CPV: Vaccines
Lots and requirements (4)Procurement structure
4 lots · no lot values publishedLot #1DTaP/IPV for the pre-school booster
Diphtheria, tetanus, pertussis and poliomyelitis (DTaP/IPV) vaccine indicated for boosting against diphtheria, tetanus, pertussis and poliomyelitis, and indicated for administration to individuals from 3 years of age. See ITO documents 2 and 4.<br/>Deliveries will be required over a period of 2 years, with the option to extend for up to an additional 24 months.
Lot #2dTaP for the maternal pertussis immunisation programme
Diphtheria, tetanus, pertussis (dTaP) vaccine indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy. See ITO documents 2 and 4.<br/>Deliveries will be required over a period of 2 years, with the option to extend for up to an additional 24 months.
Lot #3DTaP/IPV for the pre-school boosterCancelled
Contract for the provision of combined diphtheria, tetanus, and pertussis vaccine, with additional poliomyelitis antigen content. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Lot #4dTaP for the maternal pertussis immunisation programmeCancelled
Contract for the provision of combined diphtheria, tetanus, and pertussis vaccine, without additional poliomyelitis antigen content. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 11 Jan 2023, 13:10 GMT
- Last source update
- 7 Jul 2023, 12:32 BST
- Award evaluation window
- 16 Feb 2023 – …
- Authority reference
CM/PHV/24/100652- FTS notice number
2023/S 000-019462- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-039690Find a Tender
Publisher note: The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.<br/><br/>Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 16 Feb 2023, 13:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 16 Feb 2023, 13:00 GMT
Timeline
16 Feb 2023 → 7 Jul 2023 · 3 dates- Submission deadline16 Feb 2023, 13:00 GMT
- Bids opened16 Feb 2023, 13:00 GMT
- Notice published7 Jul 2023, 12:32 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete7 Jul 2023, 12:32 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Not linked to a lot2 awards | |||
| Aventis Pharma Ltd Trading As Sanofi | £1 †same award published again · counted once | — | Awarded |
| Aventis Pharma Ltd Trading As Sanofi | £1 † | — | Awarded |
Contracts
Contract 019462-2023-1 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 22 Jun 2023
- Value
- £1
- Status
- active
Contract 019462-2023-2 · Aventis Pharma Ltd Trading As Sanofi
- Signed
- 22 Jun 2023
- Value
- £1
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Aventis Pharma ltd t/a SanofiAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria